ABBV-706 is a SEZ6 targeting ADC, which is composed of the Linker-Payload conjugation and the Anti-SEZ6 Antibody (SC17) (HY-P991041). ABBV-706 exhibits high efficacy against small cell lung cancer (SCLC), neuroendocrine tumors (NENs) and central nervous system (CNS) tumors[1].